Results for tag: "Chlamydia Molecular Diagnostics"

The Chlamydia Molecular Diagnostics market is a subset of the larger Molecular Diagnostics market. Molecular Diagnostics is a type of medical testing that uses the detection of genetic material to diagnose and monitor diseases. Chlamydia Molecular Diagnostics specifically refers to the use of molecular techniques to detect the presence of Chlamydia trachomatis, a common sexually transmitted infection. These tests are used to diagnose Chlamydia infections, as well as to monitor the effectiveness of treatment. Chlamydia Molecular Diagnostics tests are typically performed on urine or swab samples, and can be used to detect both active and latent infections. These tests are highly sensitive and specific, and can be used to detect Chlamydia infections in both men and women. Companies in the Chlamydia Molecular Diagnostics market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Hologic. Show Less Read more